Broadley, S. A. and F. U. Hartl: The role of molecular chaperones in human misfolding diseases. In: FEBS Letters 583, 16, 2647-2653 (2009).
Schiffer, N. W., J. Ceraline, F. U. Hartl and S. A. Broadley: N-terminal polyglutamine-containing fragments inhibit androgen receptor transactivation function. In: Biological Chemistry 389, 12, 1455-1466 (2008).
Broadley, S. A. and F. U. Hartl: Mitochondrial stress signaling: a pathway unfolds. In: Trends in Cell Biology 18, 1, 1-4 (2008).
Schiffer, N. W., S. A. Broadley, T. Hirschberger, P. Tavan, H. A. Kretzschmar, A. Giese, C. Haass, F. U. Hartl and B. Schmid: Identification of Anti-prion Compounds as Efficient Inhibitors of Polyglutamine Protein Aggregation in a Zebrafish Model. In: The Journal of Biological Chemistry 282, 12, 9195-9203 (2007).
doi: 10.1074/jbc.M607865200
Dragovic, Z., S. A. Broadley, Y. Shomura, A. Bracher and F. U. Hartl: Molecular chaperones of the Hsp110 family act as nucleotide exchange factors of Hsp70s. In: EMBO Journal 25, 11, 2519-2528 (2006).
Haacke, A., S. A. Broadley, R. Boteva, N. Tzvetkov, F. U. Hartl and P. Breuer: Proteolytic cleavage of polyglutamine-expanded ataxin-3 is critical for aggregation and sequestration of non-expanded ataxin-3. In: Human Molecular Genetics 15, 4, 555-568 (2006).
Barral, J. M., S. A. Broadley, G. Schaffar and F. U. Hartl: Roles of molecular chaperones in protein misfolding diseases. In: Seminars in Cell & Developmental Biology 15, 1, 17-29 (2004).
The Max Planck Society does not take any responsibility for the content of this export.